Notify me when Daniel J. O'Connor files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AMAM | Ambrx Biopharma Cayman, Inc. | President and CEO, Director | $29.4M | Jul 5, 2023 | ||
| AMAM | Ambrx Biopharma, Inc. | President and CEO, Director | $0 | Mar 7, 2024 | ||
| DMAC | DiaMedica Therapeutics Inc. | Director | $0 | Feb 20, 2025 | ||
| SEEL | SEELOS THERAPEUTICS, INC. | Director | Jan 4, 2024 | |||
| ZVSA | ZyVersa Therapeutics, Inc. | Director, 10%+ Owner | Dec 12, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|